IP Library Granted Patent US 7,625,717
Granted Patent B2
US 7,625,717 · App. 11/710,655 · Granted Dec 1, 2009

Expanding the eukaryotic genetic code

Assignee: The Scripps Research Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,625,717
App. No.
11/710,655
Granted
Dec 1, 2009
Kind
B2
Abstract

This invention provides compositions and methods for producing translational components that expand the number of genetically encoded amino acids in eukaryotic cells. The components include orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases, orthogonal pairs of tRNAs/synthetases and unnatural amino acids. Proteins and methods of producing proteins with unnatural amino acids in eukaryotic cells are also provided.

Claims (30)

1. A method of producing an orthogonal aminoacyl-tRNA synthetase (O-RS) that preferentially aminoacylates an orthogonal tRNA with an unnatural amino acid in a eukaryotic cell and in the absence of the unnatural amino acid produces less than 30% of a yield of a protein of interest compared to the yield in the presence of the unnatural amino acid, the method comprising:

(a) subjecting to positive selection, in the presence of the unnatural amino acid, a population of eukaryotic cells of a first species, wherein the eukaryotic cells each comprise:

i) a member of a library of aminoacyl-tRNA synthetases (RSs),

ii) an orthogonal tRNA (O-tRNA),

iii) a polynucleotide that encodes a positive selection marker that comprises at least one selector codon, which incorporates the unnatural amino acid into the positive selection marker, and

iv) a polynucleotide that encodes a negative selection marker that comprises at least one selector codon, which incorporates the unnatural amino acid into the negative selection marker;

wherein cells that survive the positive selection comprise an active RS that aminoacylates the orthogonal tRNA (O-tRNA) in the presence of the unnatural amino acid; and

(b) subjecting the cells that survive the positive selection to negative selection in the absence of the unnatural amino acid to eliminate active RSs that aminoacylate the O-tRNA with a natural amino acid, thereby providing the O-RS that preferentially aminoacylates the O-tRNA with the unnatural amino acid; and,

wherein the polynucleotide that encodes the negative selection marker comprises an ura3 gene and the negative selection can be accomplished on a medium that comprises 5 fluoroorotic acid (5-FOA).

2. A method of producing an orthogonal aminoacyl-tRNA synthetase (O-RS) that preferentially aminoacylates an orthogonal tRNA with an unnatural amino acid in a eukaryotic cell and in the absence of the unnatural amino acid produces less than 30% of a yield of a protein of interest compared to the yield in the presence of the unnatural amino acid, the method comprising:

(a) subjecting to positive selection, in the presence of the unnatural amino acid, a population of eukaryotic cells of a first species, wherein the eukaryotic cells each comprise:

i) a member of a library of aminoacyl-tRNA synthetases (RSs),

ii) an orthogonal tRNA (O-tRNA),

iii) a polynucleotide that encodes a positive selection marker that comprises at least one selector codon, which incorporates the unnatural amino acid into the positive selection marker, and

iv) a polynucleotide that encodes a negative selection marker that comprises at least one selector codon, which incorporates the unnatural amino acid into the negative selection marker;

wherein;

cells that survive the positive selection comprise an active RS that aminoacylates the orthogonal tRNA (O-tRNA) in the presence of the unnatural amino acid; and,

(b) subjecting the cells that survive the positive selection to negative selection in the absence of the unnatural amino acid to eliminate active RSs that aminoacylate the O-tRNA with a natural amino acid, thereby providing the O-RS that preferentially aminoacylates the O-tRNA with the unnatural amino acid; and,

wherein the negative selection can be accomplished using a polynucleotide that encodes the negative selection marker that convert a selecting or screening agent to a detectable substance.

3. A method of producing an orthogonal aminoacyl-tRNA synthetase (O-RS) that preferentially aminoacylates an orthogonal tRNA with an unnatural amino acid in a eukaryotic cell and in the absence of the unnatural amino acid produces less than 30% of a yield of a protein of interest compared to the yield in the presence of the unnatural amino acid ˜ the method comprising:

(a) subjecting to positive selection, in the presence of the unnatural amino acid, a population of eukaryotic cells of a first species, wherein the eukaryotic cells each comprise:

i) a member of a library of aminoacyl-tRNA synthetases (RSs),

ii) an orthogonal tRNA (O-tRNA)

iii) a polynucleotide that encodes a positive selection marker that comprises at least one selector codon, which incorporates the unnatural amino acid into the positive selection marker, and

iv) a polynucleotide that encodes a negative selection marker that comprises at least one selector codon, which incorporates the unnatural amino acid into the negative selection marker;

wherein:

cells that survive the positive selection comprise an active RS that aminoacylates the orthogonal tRNA (O-tRNA) in the presence of the unnatural amino acid,

(b) subjecting the cells that survive the positive selection to negative selection in the absence of the unnatural amino acid to eliminate active RSs that aminoacylate the O-tRNA with a natural amino acid, thereby providing the O-RS that preferentially aminoacylates the O-tRNA with the unnatural amino acid; and,

wherein the negative selection can be accomplished using a polynucleotide that encodes the negative selection marker that convert a selecting or screening agent to a detectable substance; and,

the detectable substance is a toxic substance.

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 19, 2017
From: THE SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 044440/0879 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Nov 14, 2008
From: SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021839/0662 →
CONFIRMATORY LICENSE Recorded May 29, 2007
From: SCRIPPS RESEARCH INSTITUTE, THE
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 019352/0707 →
Continuity (6)
Division 1082586700 · Apr 16, 2004
Provisional Application 6046386900 · Apr 17, 2003
Provisional Application 6047993100 · Jun 18, 2003
Provisional Application 6049301400 · Aug 5, 2003
Provisional Application 6049654800 · Aug 19, 2003
Related Publication 20070154952A1 · Jul 5, 2007